Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces the NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:28:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:40:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:24:58.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study content, indicating the record is currently inaccessible on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-19T20:54:32.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.5 to v3.6.6, signaling a behind-the-scenes update to the page framework rather than a content change. This is a platform-level update and does not alter visible study information.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:50.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.4 to v3.6.5, signaling a small maintenance/update. It does not change study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-08T18:36:43.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.